Page 2399 - Hematology_ Basic Principles and Practice ( PDFDrive )
P. 2399

Chapter 145  Stroke  2141


            Chimowitz  MI,  Lynn  MJ,  Derdeyn  CP,  et al:  Stenting  versus  aggressive   Lansberg MG, O’Donnell MJ, Khatri P, et al: Antithrombotic and thrombo-
              medical therapy for intracranial arterial stenosis. N Engl J Med 365:993,   lytic therapy for ischemic stroke: Antithrombotic Therapy and Prevention
              2011.                                                 of Thrombosis, 9th ed: American College of Chest Physicians Evidence-
            Ederle J, Dobson J, Featherstone RL, et al: Carotid artery stenting compared   Based  Clinical  Practice  Guidelines.  Chest  141(2  Suppl):e601S–e636S,
              with endarterectomy in patients with symptomatic carotid stenosis (Inter-  2012.
              national  Carotid  Stenting  Study):  an  interim  analysis  of  a  randomised   Lees KR, Emberson J, Blackwell L, et al: Effects of Alteplase for Acute Stroke
              controlled trial. Lancet 375:985, 2010.               on  the  Distribution  of  Functional  Outcomes:  A  Pooled  Analysis  of  9
            Gladstone DJ, Spring M, Dorian P, et al: Atrial fibrillation in patients with   Trials. Stroke 47(9):2373–2379, 2016.
              cryptogenic stroke. N Engl J Med 370(26):2467–2477, 2014.  Lip GY, Tse HF, Lane DA: Atrial fibrillation. Lancet 379:648, 2012.
            Halkes PH, van Gijn J, Kappelle LJ, et al: Aspirin plus dipyridamole versus   O’Donnell  MJ,  Chin  SL,  Rangarajan  S,  et al:  Global  and  regional  effects
              aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): ran-  of  potentially  modifiable  risk  factors  associated  with  acute  stroke
              domised controlled trial. Lancet 367:1665, 2006.      in  32  countries  (INTERSTROKE):  a  case-control  study.  Lancet
            Hemphill  JC,  III,  Greenberg  SM,  Anderson  CS,  et al:  Guidelines  for  the   388(10046):761–775, 2016.
              Management of Spontaneous Intracerebral Hemorrhage: A Guideline for   Rothwell PM, Algra A, Amarenco P: Medical treatment in acute and long-
              Healthcare Professionals From the American Heart Association/American   term secondary prevention after transient ischaemic attack and ischaemic
              Stroke Association. Stroke 46(7):2032–2060, 2015.     stroke. Lancet 377:1681, 2011.
            Jauch EC, Saver JL, Adams HP, Jr, et al: Guidelines for the early manage-  Rothwell PM, Eliasziw M, Gutnikov SA, et al: Endarterectomy for symp-
              ment of patients with acute ischemic stroke: a guideline for healthcare   tomatic carotid stenosis in relation to clinical subgroups and timing of
              professionals  from  the  American  Heart  Association/American  Stroke   surgery. Lancet 363:915, 2004.
              Association. Stroke 44(3):870–947, 2013.            Sandercock PA, Counsell C, Tseng MC, et al: Oral antiplatelet therapy for
            Kernan WN, Ovbiagele B, Black HR, et al: Guidelines for the prevention of   acute ischaemic stroke. Cochrane Database Syst Rev (3):CD000029, 2014.
              stroke in patients with stroke and transient ischemic attack: a guideline for   Sandercock PA, Gibson LM, Liu M: Anticoagulants for preventing recurrence
              healthcare professionals from the American Heart Association/American   following  presumed  non-cardioembolic  ischaemic  stroke  or  transient
              Stroke Association. Stroke 45(7):2160–2236, 2014.     ischaemic attack. Cochrane Database Syst Rev (2):CD000248, 2009.
            Koton S, Rothwell PM: Performance of the ABCD and ABCD2 scores in   Tomaselli GF: Prevention of cardiovascular disease and stroke: meeting the
              TIA patients with carotid stenosis and atrial fibrillation. Cerebrovasc Dis   challenge. JAMA 306:2147, 2011.
              24:231, 2007.                                       Yuan ZH, Jiang JK, Huang WD, et al: A meta-analysis of the efficacy and
            Langhorne P, Bernhardt J, Kwakkel G: Stroke rehabilitation. Lancet 377:1693,   safety of recombinant activated factor VII for patients with acute intra-
              2011.                                                 cerebral hemorrhage without hemophilia. J Clin Neurosci 17:685, 2010.
   2394   2395   2396   2397   2398   2399   2400   2401   2402   2403   2404